Resources

The list of variants for sickle cell disease, beta thalassemia and other hemoglobinopathies are captured in this resource.

This publication includes information published in accordance with subsection 53B(5) of the
Medical Indemnity Act 2002. It also includes information reported to the Secretary of the Department of Health and Aged Care in accordance with section 20 of the Medical Indemnity Rules 2020.

This infographic shows the number of flu (influenza) vaccinations reported to the Australian Immunisation Register (AIR) during 2021–2024, since 1 March.

Aged care assessors should print this fact sheet and give it to older people during aged care assessments. It provides information for older people about sharing My Aged Care support plans with My Health record.

Aged care assessors can print this document and give it to older people during assessments. It provides information for older people about My Aged Care support plans, My Health Record, sharing support plans with My Health Record, key contacts and useful links.

The ATAGI 2024 Annual Statement on Immunisation is the fourth publication in this series. The statement highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases in Australia in 2023, and includes advice to address key issues for 2024.

This fact sheet contains information for parents and carers on the changes to vaping in Australia.

This fact sheet contains information on the changes to vaping in Australia.

Use these social media tiles to promote the changes to vaping in Australia from 1 October 2024.

This fact sheet contains information for prescribers on the changes to vaping in Australia.

This poster outlines the COVID-19 vaccine doses recommended for each age and population group.

These guidelines contain the general, initial and ongoing eligibility requirements to access asfotase alfa (Strensiq®) for perinatal- and infantile-onset hypophosphatasia under the Life Saving Drugs Program.

Treating physicians use this application form to apply for a patient to access LSDP medication for HPP for the first time, or after a break.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for HPP.

Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program.

This manual will help Aged care providers submit a specialisation application and to learn how the Specialisation Verification assessment process works.

This fact sheet provides advice to health professionals on the changes to Meningococcal ACWY vaccines under the National Immunisation Program (NIP).

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

The Statement of Expectations sets out the role for the Aged Care Quality and Safety Commission in preparing the sector for the new Aged Care Act.

This document outlines the updates to the LSDP’s testing requirements for Pompe disease, Gaucher disease (type 1), and mucopolysaccharidosis types I, II, and VI arising from the LSDP Expert Panel’s Medicines Reviews Recommendations.

This fact sheet supports care recipients to understand their monthly statement and the responsible use of Home Care Package funds. It accompanies the Care Recipient Guidance – Understanding your Home Care Package statement.

These are the presentation slides for the Residential aged care funding reform update webinar held on September 18 2024.